Role of δ2 opioid receptor in cardioprotection against hypoxia-reoxygenation injury

Journal of Cardiovascular Pharmacology

Volumn 60, Issue 3, 2012, Pages 253-261

  Shen, Hong ^a   Ben, Qiwen ^b   Zhang, Yaping ^a   Jiang, Genxi ^b   Yao, Chenling ^a   Shi, Dongwei ^a   Sun, Zhan ^a   Tong, Chaoyang ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

cardioprotection; hypoxia reoxygenation; MEK ERK1 2 pathway; opioid receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; DELTA 2 OPIATE RECEPTOR; DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN E; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE INJURY; HEART PROTECTION; HYPOXIA REOXYGENATION INJURY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; CELLS, CULTURED; ENKEPHALIN, LEUCINE-2-ALANINE; HEK293 CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MYOCYTES, CARDIAC; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA;

EID: 84866308009     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31825e215f     Document Type: Article

References (29)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136. (Pubitemid 17174962)
2. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 1991;84:341-349.
3. Yellon DM, Alkhulaifi AM, Browne EE, et al. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res. 1992;26:983-987.
4. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning and morphineinduced cardioprotection involve the delta (d)-opioid receptor in the intact rat heart. J Mol Cell Cardiol. 1997;29:2187-2195. (Pubitemid 27348529)
5. Schultz JE, Hsu AK, Nagase H, et al. TAN-67, a d1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol. 1998;274:H909-H914.
6. Fryer RM, Wang Y, Hsu AK, et al. Essential activation of PKC-d in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol. 2001; 280:H1346-H1353.
7. Sigg DC, Coles JA, Oeltgen PR, et al. Role of d-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol. 2002;282:H1953-H1960. (Pubitemid 34663000)
8. Weinbrenner C, Schulze F, Sarvary L, et al. Remote preconditioning by infrarenal aortic occlusion is operative via d1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res. 2004;61:591-599. (Pubitemid 38210164)
9. Maslov LN, Lishmanov YB, Oeltgen PR, et al. Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction. Acad Emerg Med. 2010;17:1239-1246.
10. Maslov LN, Lishmanov YB, Oeltgen PR, et al. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system. Life Sci. 2009; 84:657-663.
11. Fryer RM, Hsu AK, Eells JT, et al. Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels. Circ Res. 1999;84:846-851. (Pubitemid 29181492)
12. Fryer RM, Wang Y, Hsu AK, et al. Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway. J Pharmacol Exp Ther. 2001;299:477-482. (Pubitemid 32979658)
13. Fryer RM, Pratt PF, Hsu AK, et al. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid induced cardioprotection. J Pharmacol Exp Ther. 2001;296:642-649. (Pubitemid 32112495)
14. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 1998;186:3-12. (Pubitemid 28438540)
15. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res. 2004;61:427-436. (Pubitemid 38210149)
16. Ikeda Y, Miura T, Sakamoto J, et al. Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. Basic Res Cardiol. 2006;101:418-426. (Pubitemid 44275875)
17. Hwang KC, Lim SY, Kwon HM, et al. Phospholipase C-delta1 rescues intracellular Ca2+ overload in ischemic heart and hypoxic neonatal cardiomyocytes. J Steroid Biochem Mol Biol. 2004;91:131-138. (Pubitemid 38992807)
18. Wang GW, Scheschke DA, Kang YJ. Metallothionein-overexpressing neonatal mouse cardiomyocytes are resistant to H2O2 toxicity. Am J Physiol Heart Circ Physiol. 1999;276(pt 2):H167-H175. (Pubitemid 29065635)
19. Mantwill K, Kohler-Vargas N, Bernshausen A, et al. Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: Implications for combinatorial treatment regimen with chemotherapeutic agents. Cancer Res. 2006;66:7195-7202. (Pubitemid 44197698)
20. Welder AA, Grant R, Bradlaw J, et al. A primary culture system of adult rat heart cells for the study of toxicologic agent. In Vitro Cell Dev Biol. 1991;27A:921-926.
21. Iyengar R, and Hildebrandt JD. G protein Pathways: g Proteins and Their Regulators. Waltham, MA: ACADEMIC Press, Vol. 343; 2002:81.
22. Rutten M, Govindaswami M, Oeltgen P, et al. Post-treatment with the novel deltorphin E, a delta2-opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in behaving rats. Shock. 2008;29:42-48.
23. Huang MH, Nguyen V, Wu Y, et al. Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: Adrenopeptidergic co-signalling. Cardiovasc Res. 2009;84:452-460.
24. Hayashi T, Tsao LI, Su TP. Antiapoptotic and cytotoxic properties of delta opioid peptide (D-Ala(2), D-Leu(5))enkephalin in PC12 cells. Synapse. 2002;43:86-94.
25. Bonni A, Brunet A, West AE, et al. Cell survival promoted by the ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999;286:1358-1362.
26. Fryer RM, Hsu AK, Nagase H, et al. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATPsensitive potassium channels. J Pharmacol Exp Ther. 2000;294:451-457. (Pubitemid 30490815)
27. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by d1- but not m- or k-opioid receptors. Circulation. 1998;97:1282-1289. (Pubitemid 28169181)
28. Gottlieb RA, and Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann N Y Acad Sci. 1999;874:412-426. (Pubitemid 29353249)
29. Kajsture J, Cheng W, Reiss K, et al. Apoptosis and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107. (Pubitemid 26041012)